Accounts and other information 2.4 Other business segment information Other significant expenses recognised within operating profit 2011 2010 2009 $ million $ million $ million Orthopaedics 26 822 Endoscopy 6 22 Advanced Wound Management 8 56 40 15 30 The $40m incurred in 2011 relates to restructuring and rationalisation expenses 2010 $15m relates to restructuring and rationalisation expenses, 2009 $30m relates to acquisitions related costs and restructuring and rationalisation expenses.
2010 2009 2011 numbers numbers numbers Average number of employees Orthopaedics 5,280 5,045 4,853 Endoscopy 2,331 2,134 1,888 Advanced Wound Management 2,993 3,023 3,132 10,743 10,172 9,764 3 Operating profit Accounting policies Research and development The Group considers that the regulatory, technical and market uncertainties inherent in the development of new products means that development costs should not be capitalised as intangible assets until products receive approval from the appropriate regulatory body.
Substantially all development expenditure is complete by the time the product is submitted for regulatory approval.
Consequently the majority of expenditure on research and development is expensed as incurred.
Advertising costs Expenditure on advertising costs is expensed as incurred.
2011 2010 2009 $ million $ million $ million Revenue 4,270 3,962 3,772 Cost of goods sold i 1,140 1,031 1,030 Gross profit 3,130 2,931 2,742 Research and development expenses 167 151 155 Selling, general and administrative expenses: Marketing, selling and distribution expenses ii 1,526 1,414 1,351 Administrative expenses iii iv v 575 446 513 1,860 1,864 2,101 Operating profit 862 920 723 i In 2011, $7m of restructuring and rationalisation expenses related to cost of goods sold 2010 no restructuring and rationalisation expenses or acquisition related costs, 2009 $15m of restructuring and rationalisation expenses and $12m of acquisition related costs.
ii 2011 includes $nil of restructuring and rationalisation expenses 2010 $3m of restructuring and rationalisation expenses, 2009 $7m of acquisition related costs and $10m of restructuring and rationalisation expenses.
iii 2011 includes $42m of amortisation of other intangible assets 2010 $34m, 2009 $26m.
iv 20 11 includes $33m of restructuring and rationalisation expenses and $36m of amortisation acquisition intangibles 2010 $12m of restructuring and rationalisation expenses and $34m of amortisation acquisition intangibles, 2009 $7m of acquisition related costs, $17m of restructuring and rationalisation expenses and $66m of amortisation of acquisition intangibles and impairments.
v 2011 includes $23m relating to legal provision 2010 $nil, 2009 $nil.
vi Items detailed in i, ii, iv and v are excluded from the calculation of trading profit.
93 Smith & Nephew Annual Report 2011 Accounts and other information Corporate Governance Business Review Strategy, KPIs & Risk management Overview Accounts and other information Notes to the Group accounts continued Operating profit is stated after charging the following items: 2011 2010 2009 $ million $ million $ million Amortisation of acquisition intangibles 36 34 34 Amortisation of other intangible assets 42 34 26 Impairment of intangible assets and goodwill 32 Depreciation of property, plant and equipment 217 203 206 Loss on disposal of property, plant and equipment and software 9 15 14 Impairment of investments 2 2 Minimum operating lease payments for land and buildings 33 31 27 Minimum operating lease payments for other assets 32 28 28 Advertising costs 90 83 71 3.1 Staff costs Staff costs during the year amounted to: 2011 2010 2009 Notes $ million $ million $ million Wages and salaries 930 817 768 Social security costs 99 91 86 Pension costs including retirement healthcare 19 60 64 64 Share based payments 24 30 21 18 1,123 989 936 3.2 Audit Fees Information about the nature and cost of services provided by auditors 2011 2010 2009 $ million $ million $ million Audit services: Group accounts 1 11 Other services: Local statutory audit pursuant to legislation 2 22 Taxation services: Compliance services 1 11 Advisory services 1 11 Total auditors remuneration 5 55 Arising: In the UK 2 22 Outside the UK 3 33 5 55 3.3 Restructuring and rationalisation expenses In 2011, restructuring and rationalisation costs of $40m 2010 $15m, 2009 $42m were incurred in the twelve month period to 31 December 2011.
Charges of $14m 2010 $15m, 2009 $42m related to the earnings improvement programme which was completed in the year.
Charges of $26m 2010 $nil were also incurred, relating mainly to people costs associated with the structural and process changes announced in August 2011.
3.4 Legal provision In 2011, the Group has established a provision of $23m in connection with the previously disclosed investigation by the U. S. Securities and Exchange Commission SEC and Department of Justice DOJ into potential violations of the U. S. Foreign Corrupt Practices Act in the medical devices industry.
On 6 February 2012, Smith & Nephew announced that it had reached settlement with the SEC and DOJ in connection with this matter.
Smith & Nephew has committed to pay slightly less than $23m in fines and profit disgorgement, maintain an enhanced compliance programme, and appoint an independent monitor for at least 18 months to review and report on its compliance programme.
